(Q24314906)

1

0 references

X Chen

2

0 references

J Fu

3

0 references

M Chen

4

0 references

H Zhu

5

0 references

A Roher

6

0 references

T Slattery

7

0 references

L Zhao

8

0 references

M Nagashima

9

0 references

J Morser

10

0 references

A Migheli

11

0 references

D Stern

13

0 references

A M Schmidt

Tau protein and the neurofibrillary pathology of Alzheimer's disease

14

0 references

language of work or name

English

0 references

publication date

22 August 1996

0 references

published in

Nature

0 references

volume

382

0 references

issue

6593

0 references

page(s)

685-91

0 references

cites work

1 reference

7 January 2021

The Alzheimer's disease sphinx: a riddle with plaques and tangles

1 reference

7 January 2021

Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth

1 reference

7 January 2021

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

1 reference

7 January 2021

The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes

1 reference

7 January 2021

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

1 reference

7 January 2021

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

1 reference

7 January 2021

Hydrogen peroxide mediates amyloid beta protein toxicity

1 reference

7 January 2021

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

7 January 2021

Activation of macrophages by Alzheimer beta amyloid peptide

1 reference

7 January 2021

β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

1 reference

7 January 2021

?1-Antichymotrypsin Binding to Alzheimer A? Peptides Is Sequence Specific and Induces Fibril Disaggregation In Vitro

1 reference

7 January 2021

The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex

1 reference

7 January 2021

Amyloid beta-protein activates tachykinin receptors and inositol trisphosphate accumulation by synergy with glutamate

1 reference

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

7 January 2021

Avid binding of beta A amyloid peptide to its own precursor

1 reference

7 January 2021

Transthyretin sequesters amyloid beta protein and prevents amyloid formation

1 reference

7 January 2021

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

1 reference

7 January 2021

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

1 reference

7 January 2021

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

1 reference

7 January 2021

Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.

1 reference

7 January 2021

Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons

1 reference

7 January 2021

Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium

1 reference

7 January 2021

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

1 reference

7 January 2021

Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes

1 reference

7 January 2021

Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products

1 reference

7 January 2021

An immortalized cell line expresses properties of activated microglial cells

1 reference

7 January 2021

Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

1 reference

7 January 2021

Microglia in degenerative neurological disease.

1 reference

7 January 2021

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

1 reference

7 January 2021

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

1 reference

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

7 January 2021

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

7 January 2021

Attachment and culture of dissociated cells from rat embryo cerebral hemispheres on polylysine-coated surface

1 reference

7 January 2021

Effect of fatty acid profiles on the susceptibility of cultured rabbit tracheal epithelial cells to hyperoxic injury

1 reference

7 January 2021